Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;104(4):e14637.
doi: 10.1111/cbdd.14637.

Anti-metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes

Affiliations

Anti-metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes

Nur Sena Sivri et al. Chem Biol Drug Des. 2024 Oct.

Abstract

Apitherapy has started to gain tremendous recognition because of extraordinary pharmacological importance of honeybee-related ingredients and their derivatives. There has been a renewed interest in the bee venom-based therapies. Interdisciplinary researchers are studying the chemistry and translational value of venom for effective cancer treatment. Bee venom and its major component, melittin, are cytotoxic in cancer cells. In this study, MTT and scratch assays were performed for analysis of melittin-mediated antimetastatic effects. QPCR was used for expression profiling of metastasis-related genes. Three anti-metastatic genes (BRMS1, DRG1, and KAI1/CD82) were studied for the first time after bee venom and melittin treatment in MDA-MB-231 breast cancer cells compared with normal breast cells, and two prometastatic genes (EGFR and WNT7B) were also examined. KAI1/CD82 and BRMS1 are the negative regulators of EGFR. WNT7B is a negative regulator of KAI1/CD82. Selective cytotoxicity of bee venom and melittin was found to be higher as compared to cisplatin. Melittin induced an increase in the expression of BRMS1 and DRG1, whereas bee venom upregulated DRG1 and KAI1/CD82 expression in breast cancer. WNT7B was downregulated in bee venom-treated breast cancer cells. Results suggested that bee venom/melittin exerted antimetastatic effects primarily through upregulation of BRMS1, DRG1, and KAI1/CD82, and downregulation of WNT7B.

Keywords: bee venom; breast cancer; melittin; metastasis; scratch assay.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Abdulmalek, S., N. Mostafa, M. Gomaa, M. El‐Kersh, A. I. Elkady, and M. Balbaa. 2022. “Bee Venom‐Loaded EGFR‐Targeting Peptide‐Coupled Chitosan Nanoparticles for Effective Therapy of Hepatocellular Carcinoma by Inhibiting EGFR‐Mediated MEK/ERK Pathway.” PLoS One 17, no. 8: e0272776. https://doi.org/10.1371/JOURNAL.PONE.0272776.
    1. Ayazoglu Demir, E., A. Colak, S. C. Uzuner, and O. Bekircan. 2021. “Cytotoxic Effect of a 3‐(4‐Chlorophenyl)‐5‐(4‐Methoxybenzyl)‐4H‐1,2,4‐Triazole Derivative Compound in Human Melanoma Cells.” International Journal of Biology and Chemistry 14, no. 1: 139–148. https://doi.org/10.26577/IJBCH.2021.V14.I1.015.
    1. Badawi, J. K. 2021. “Bee Venom Components as Therapeutic Tools Against Prostate Cancer.” Toxins 13, no. 5: 337. https://doi.org/10.3390/toxins13050337.
    1. Baig, R. M., A. J. Sanders, M. A. Kayani, and W. G. Jiang. 2012. “Association of Differentiation‐Related Gene‐1 (DRG1) With Breast Cancer Survival and In Vitro Impact of DRG1 Suppression.” Cancers 4, no. 3: 658–672. https://doi.org/10.3390/cancers4030658.
    1. Çelik Uzuner, S., E. Birinci, S. Tetikoğlu, C. Birinci, and S. Kolaylı. 2021. “Distinct Epigenetic Reprogramming, Mitochondrial Patterns, Cellular Morphology, and Cytotoxicity After Bee Venom Treatment.” Recent Patents on Anti‐Cancer Drug Discovery 16, no. 3: 377–392. https://doi.org/10.2174/1574892816666210422125058.

MeSH terms

LinkOut - more resources